Binah.ai is using the smartphone camera for contactless, video-based blood pressure measurement, which the company says is a first-of-its kind technology, thereby enabling remote patient monitoring. But the FDA hasn't approved the technology yet.
The supply chain needs of the pharmaceutical industry are growing increasingly complex, particularly with the growth of cell and gene therapies that require timely delivery of medication components that have to be kept at stable temperatures.
A new report, Resilience in volatility: Modernizing the supply chain from Microsoft highlights factors that have stressed the supply chain over the past 18 months and how companies are responding to this crisis as they lay the groundwork to minimize the impact of global events in the future.
INVEST 2022 is going to be held March 28-30 in at the Ritz Carlton hotel in Chicago. This year, we have four new categories reflecting the pandemic-reality and how it has reshaped healthcare. Apply now for a chance to pitch LIVE in front of VC judges. Please note that companies that have pitched in the last 12 months at a MedCity event are ineligible to apply. Selected finalists will be asked to register for the conference at a reduced rate. Deadline is January 15.
By Julie Rovner, Kaiser Health News Friday, January 7, 2022 7:22 PM
Lower courts have split on whether the federal government has the authority to issue such rules and whether they can take effect while the cases are argued.
It's the first week of the new year, and the life sciences sector continued the IPO momentum of 2021 as Wall Street welcomed three new biotech companies. Here's a look at the IPOs of Amylyx Pharmaceuticals, CinCor, and Vigil Neuroscience, which raised a combined $482 million to support work on drugs addressing neurodegenerative and cardiovascular disorders.
By Samantha Young, Kaiser Health News Friday, January 7, 2022 12:54 PM
Voters will weigh whether to overturn a state law that bans flavored tobacco products and will likely consider increasing the cap on medical malpractice awards.
The CEO of Surescripts believes we are living in an unpredictable world coupled with an explosion of innovation that aims to solve challenges like the cost of medications, administrative inefficiency and gaps in patient information.
In 2021 biotech had a median deal of $10 million and an average deal of $36.9 million, according to the report by PitchBook Data. Comparatively, medtech locked in an median of $3.9 million and $12.6 million average.
Sanofi's new alliance with artificial intelligence biotech Exscientia spans up to 15 small molecule drugs in cancer and immunology. If drugs from the partnership reach the market, Exscientia could earn as much as $5.2 billion in milestone payments.
By Dr. Namrata Rastogi Friday, January 7, 2022 8:15 AM
Child and adolescent mental health, palliative care and clinical AI are among opportunities that investors should consider closely this year an in the future.
Every company will eventually face an audit. Download this FREE general audit checklist to evaluate your organization and take proactive steps guaranteed to prepare you in order pass an audit when the time comes.
No comments